Abiomed Inc (ABMD) 123.53 $ABMD ABIOMED Falls 1
Post# of 273254
ABIOMED Falls 1.77% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Sep 23, 1:55PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $123.06 to a high of $126.09. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $124.43 on volume of 173,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ABMD: 123.53 (-2.84)
CryoLife Hits a 52-Week High on Strong Growth Prospects
Zacks Equity Research - Zacks Investment Research - Fri Sep 23, 8:25AM CDT
Share price of CryloLife, Inc. (CRY), a leading medical device and tissue processing company, scaled a new 52-week high of $18.64 on Sep 22, eventually closing a bit lower at $18.56.
ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), IDXX: 111.36 (-1.73), CRY: 18.14 (-0.42)
ABIOMED Has Returned 50.7% Since SmarTrend Recommendation (ABMD)
Comtex SmarTrend(R) - Thu Sep 22, 12:52PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 7 months, ABIOMED has returned 50.65% as of today's recent price of $127.00.
ABMD: 123.53 (-2.84)
Thermo Fisher Adds FEI Co., Inorganic Expansion Continues
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 6:57AM CDT
Thermo Fisher Scientific, Inc. (TMO) recently closed the acquisition of FEI Company, Inc.
ABMD: 123.53 (-2.84), TMO: 157.66 (unch), CPHD: 52.50 (unch), CRY: 18.14 (-0.42)
Watch for ABIOMED to Potentially Pullback After Gaining 3.39% Yesterday
Comtex SmarTrend(R) - Thu Sep 15, 3:32PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $118.09 to a high of $122.98. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $119.48 on volume of 173,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)
40.6% Return Seen to Date on SmarTrend ABIOMED Call (ABMD)
Comtex SmarTrend(R) - Thu Sep 15, 12:23AM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 40.59% as of today's recent price of $118.52.
ABMD: 123.53 (-2.84)
ABIOMED Up 40.3% Since SmarTrend Uptrend Call (ABMD)
Comtex SmarTrend(R) - Wed Sep 07, 1:07PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 6 months, ABIOMED has returned 40.30% as of today's recent price of $118.28.
ABMD: 123.53 (-2.84)
Technical Roundup on Medical Appliances & Equipment Stocks -- Zimmer Biomet, Stryker, ABIOMED, and Spectranetics
PR Newswire - Thu Aug 18, 7:31AM CDT
Stock-Callers.com is currently focused on the Medical Appliances and Equipment segment, which includes companies that manufacture medical supplies such as surgical and medical instruments, dental equipment, and surgical appliances. According to IBISWorld, global revenue of this industry is about $350 billion. Let us take a look at today's lineup: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Stryker Corp. (NYSE: SYK), ABIOMED Inc. (NASDAQ: ABMD), and The Spectranetics Corp. (NASDAQ: SPNC). Sign up today and download for free the research reports for the stocks covered today at:
SPNC: 24.24 (-0.56), ABMD: 123.53 (-2.84), ZBH: 128.33 (-0.54), SYK: 117.76 (-0.68)
ABIOMED Set to Possibly Pullback After Yesterday's Rally of 2.63%
Comtex SmarTrend(R) - Tue Aug 09, 2:56PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $120.81 to a high of $123.93. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $122.98 on volume of 292,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)
ABIOMED Shares Up 41.9% Since SmarTrend's Buy Recommendation (ABMD)
Comtex SmarTrend(R) - Mon Aug 08, 12:48PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 41.87% as of today's recent price of $119.60.
ABMD: 123.53 (-2.84)
Weight Watchers (WTW) Misses Q2 Earnings, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 9:00AM CDT
Weight Watchers International Inc. (WTW) reported earnings of 46 cents per share, which missed the Zacks Consensus Estimate by 3 cents.
ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), NTRI: 29.59 (-0.84), WTW: 10.44 (-0.26)
Acadia Healthcare (ACHC) Beats on Q2 Earnings & Revenues
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 9:34AM CDT
Shares of Acadia Healthcare Company Inc have had a crazy run since the company posted second-quarter 2016 results on Jul 29.
ACHC: 49.54 (-0.78), HCA: 76.12 (-0.26), ABMD: 123.53 (-2.84), WOOF: 67.51 (-2.14)
Abiomed (ABMD) Beats Q1 Earnings & Revenues, Shares Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 7:35AM CDT
Abiomed reported earnings of 29 cents per share, which beat the Zacks Consensus Estimate by 7 cents.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), CPHD: 52.50 (unch)
SmarTrend Watching for Potential Pullback in Shares of ABIOMED After 3.56% Gain
Comtex SmarTrend(R) - Fri Jul 29, 3:02PM CDT
ABIOMED (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $115.24 to a high of $119.93. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $116.45 on volume of 462,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ABMD: 123.53 (-2.84)
Cepheid's (CPHD) Q2 Loss Narrower than Estimate, View Up
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:09PM CDT
Cepheid (CPHD) posted second-quarter 2016 adjusted loss per share of 9 cents.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), CPHD: 52.50 (unch)
GNC Holdings (GNC) Tops Q2 Earnings, Suspends '16 View
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 2:01PM CDT
GNC Holdings (GNC) ended second-quarter 2016 on a disappointing note as its revenue figure failed to meet the Zacks Consensus Estimate.
BABY: 43.99 (-0.39), ABMD: 123.53 (-2.84), MASI: 59.77 (-0.55), GNC: 20.15 (-0.20)
Shares of ABMD Up 42.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Jul 29, 12:54PM CDT
SmarTrend identified an Uptrend for ABIOMED (NASDAQ:ABMD) on March 7th, 2016 at $84.30. In approximately 5 months, ABIOMED has returned 42.24% as of today's recent price of $119.91.
ABMD: 123.53 (-2.84)